NDC 50242-088 – Kadcyla
Trastuzumab Emtansine 20 mg/mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC50242-088
Product details
- Brand name
- Kadcyla
- Generic name
- Ado-trastuzumab Emtansine
- Labeler
- Genentech, Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA125427
- Marketed since
- February 22, 2013
- Listing expires
- December 31, 2027
Active ingredients
- Trastuzumab Emtansine 20 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50242-088-01 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-088-01) / 5 mL in 1 VIAL, SINGLE-USE | Feb 22, 2013 |
Other Kadcyla products
- 50242-087 Trastuzumab Emtansine 20 mg/mL · Injection, Powder, Lyophilized, For Solution · Genentech, Inc.